Maravai Lifesciences Holdings Inc (MRVI) Stock Analysis

Maravai Lifesciences Holdings Inc (MRVI) is a publicly traded company in the HEALTHCARE sector. It trades at $4.83, carries a market capitalization of $1.77B. This page summarizes the public market data, fundamentals, and frequently asked questions for MRVI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Maravai Lifesciences Holdings Inc currently has a Neutral sentiment score of 0.06.

About Maravai Lifesciences Holdings Inc

Maravai Lifesciences Holdings, Inc. is a premier life sciences company based in San Diego, California, dedicated to supporting the advancement of drug therapies, diagnostics, and innovative vaccines. The company boasts a comprehensive portfolio of products and services that cater to the evolving needs of the pharmaceutical and biotechnology sectors, thereby playing a pivotal role in the advancement of human disease research. Maravai's unwavering focus on quality and innovation positions it fa...

GNG Research Analysis

GNG Research scores Maravai Lifesciences Holdings Inc (MRVI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MRVI.

Frequently Asked Questions

Does MRVI pay dividends?

Maravai Lifesciences Holdings Inc (MRVI) does not currently pay a regular dividend.

What is MRVI's market cap?

Maravai Lifesciences Holdings Inc (MRVI) has a market capitalization of $1.77B with a current stock price of $4.83.